Related Experiment Video
Updated: Mar 8, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case
A E Dorofeyev1, O A Rassokhina, A A Dorofeyeva
1National Medical University n.a.A.A.Bogomoletz, Kiev, Ukraine.
Late-onset ulcerative colitis (UC) in adults presents unique challenges. This case highlights a 57-year-old male with severe UC, initially treated with mesalazine and steroids, who achieved remission with infliximab therapy.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Case Study
Background:
- Late-onset ulcerative colitis (UC) in adults often exhibits a more aggressive clinical course compared to younger patients.
- Early diagnosis and management are crucial as UC in older adults may be linked to precancerous conditions.
Observation:
- A 57-year-old male presented with acute severe UC symptoms including bloody diarrhea, abdominal pain, urgency, and dehydration.
- Initial colonoscopy revealed diffuse inflammation, erosions, and ulcers; histological evaluation favored UC.
- The patient showed limited response to mesalazine and oral steroids, necessitating intravenous steroids and subsequently infliximab.
Findings:
- Initial treatment with mesalazine and prednisone yielded suboptimal results.
- Intravenous dexamethasone provided partial improvement, but infliximab induction therapy led to significant symptom reduction.
- The patient developed herpes zoster infection during treatment, requiring famciclovir, but continued infliximab maintenance therapy achieved stable remission.
Implications:
- This case underscores the importance of considering late-onset UC and its potential aggressive nature.
- It demonstrates the efficacy of infliximab in managing severe, late-onset UC refractory to conventional therapies.
- The case also highlights the need for vigilance regarding opportunistic infections, such as herpes zoster, during immunosuppressive therapy for UC.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Ulcerative Colitis in IBD

